|
|
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
美洛昔康纳米晶注射液用于成人腹腔镜术后镇痛的多中心、随机、双盲、安慰剂平行对照的III期临床研究
[Translation] A multi-center, randomized, double-blind, placebo-controlled phase III clinical study of Meloxicanamicine Injection for post-laparoscopic analgesia in adults
评价美洛昔康纳米晶注射液用于成人腹腔镜术后镇痛的有效性与安全性
[Translation] To evaluate the effectiveness and safety of Meloxicanamycin injection for analgesia after laparoscopic surgery in adults
一项评价雾化吸入XYP-001在健康成年人及特发性肺纤维化患者人群中安全性、耐受性以及药代动力学特征的I期临床研究
[Translation] A phase I clinical study evaluating the safety, tolerability and pharmacokinetics of nebulized XYP-001 in healthy adults and patients with idiopathic pulmonary fibrosis
主要研究目的(SAD):评价单次雾化吸入XYP-001后受试者的安全性和耐受性。
次要研究目的(SAD):评价单次雾化吸入XYP-001后受试者的XYP-001及其代谢产物的药代动力学特征。
主要研究目的(MAD):评价多次雾化吸入XYP-001后受试者的安全性和耐受性。
次要研究目的(MAD):评价多次雾化吸入XYP-001后受试者的XYP-001及其代谢产物的药代动力学特征及稳态情况; 评价雾化吸入XYP-001后IPF受试者的XYP-001及其代谢产物的痰液药物峰浓度和谷浓度。
[Translation] Main research purpose (SAD): To evaluate the safety and tolerability of subjects after a single nebulized inhalation of XYP-001.
Secondary research purpose (SAD): To evaluate the pharmacokinetic characteristics of XYP-001 and its metabolites after a single aerosol inhalation of XYP-001.
Main research purpose (MAD): To evaluate the safety and tolerability of subjects after repeated aerosol inhalation of XYP-001.
Secondary research purpose (MAD): To evaluate the pharmacokinetic characteristics and steady state of XYP-001 and its metabolites in subjects after repeated aerosol inhalation of XYP-001; The sputum drug peak and trough concentrations of XYP-001 and its metabolites were tested.
沙美特罗替卡松吸入粉雾剂治疗成人哮喘有效性和安全性的多中心、随机、盲法、阳性平行对照临床研究
[Translation] A multicenter, randomized, blinded, positive parallel controlled clinical study on the efficacy and safety of salmeterol and ficasone inhalation powder inhalation in adults with asthma
评价沙美特罗替卡松吸入粉雾剂治疗成人哮喘的有效性和安全性
[Translation] To evaluate the efficacy and safety of salmeterol and ficasone inhalation powder in the treatment of asthma in adults
100 Clinical Results associated with Health Yuan Haibin Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Health Yuan Haibin Pharmaceutical Co., Ltd.
100 Deals associated with Health Yuan Haibin Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Health Yuan Haibin Pharmaceutical Co., Ltd.